Megge Miller, Paul Roche, Keflemariam Yohannes, Jenean Spencer, Mark Bartlett, Julia Brotherton, Jenny Hutchinson, Martyn Kirk, Ann McDonald, Claire Vadjic
Other communicable disease surveillance
Laboratory Virology and Serology Reporting Scheme
The Laboratory Virology and Serology Reporting Scheme (LabVISE) is a passive surveillance scheme based on voluntary reports of infectious agents from sentinel virology and serology laboratories around Australia. LabVISE provides data on diagnoses of a number of infectious viruses, parasites and fungi. Interpretation of data from LabVISE is limited by uncertainties regarding its representativeness, lack of denominator data to calculate positivity rates, variable reporting coverage over time and lack of consistent case definitions. LabVISE has an important role in supplementing information of diseases under surveillance in NNDSS and in monitoring infectious agents that are not reported by other surveillance systems.
In 2003, a total of 13 laboratories reported 23,160 infectious agents to LabVISE. This represents a 12 per cent decline in the number of reports received in 2002 (Table 22). The largest number of reports were from Queensland (28%), South Australia (26%) and New South Wales (17%, Table 22).
Table 22. Infectious agents reported to the Laboratory Virology and Serology Reporting Scheme, 2003, by state or territory
Organism | State or territory | Total 2003 | Total 2002 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
ACT | NSW | NT | Qld | SA | Tas | Vic | WA | |||
Measles virus | – |
7 |
1 |
5 |
24 |
– |
33 |
1 |
71 |
16 |
Mumps virus | – |
1 |
– |
2 |
2 |
– |
1 |
4 |
10 |
16 |
Rubella virus | – |
2 |
– |
13 |
4 |
– |
4 |
3 |
26 |
92 |
Hepatitis A virus | 1 |
2 |
6 |
17 |
12 |
– |
4 |
45 |
87 |
71 |
Hepatitis D virus | – |
– |
– |
– |
2 |
– |
10 |
7 |
19 |
7 |
Ross River virus | 2 |
56 |
48 |
1,016 |
19 |
– |
7 |
90 |
1,238 |
423 |
Barmah Forest virus | – |
52 |
8 |
336 |
2 |
– |
1 |
9 |
408 |
203 |
Sindbis virus | – |
– |
– |
– |
– |
– |
1 |
– |
1 |
– |
Dengue | – |
3 |
6 |
– |
1 |
– |
1 |
28 |
39 |
168 |
Murray Valley encephalitis virus | – |
– |
1 |
– |
– |
– |
– |
– |
1 |
7 |
Flavivirus (unspecified) | – |
– |
1 |
110 |
– |
– |
11 |
– |
122 |
43 |
Adenoviruses | 1 |
192 |
13 |
72 |
412 |
2 |
111 |
159 |
962 |
1,069 |
Herpesviruses | 51 |
444 |
97 |
1,540 |
1,313 |
9 |
220 |
621 |
4,295 |
4,650 |
Other DNA viruses | 1 |
8 |
– |
77 |
9 |
– |
84 |
100 |
279 |
– |
Picornaviruses | 2 |
441 |
10 |
17 |
21 |
5 |
30 |
304 |
830 |
1,372 |
Ortho/paramyxoviruses | 4 |
1,371 |
39 |
399 |
1,594 |
47 |
472 |
644 |
4,570 |
6,289 |
Other RNA viruses | 3 |
425 |
15 |
2 |
508 |
16 |
486 |
342 |
1,797 |
2,555 |
Chlamydia trachomatis | 20 |
585 |
55 |
1,528 |
1,025 |
47 |
46 |
991 |
4,296 |
3,874 |
Chlamydia pneumoniae | 3 |
6 |
1 |
– |
– |
– |
– |
5 |
15 |
32 |
Chlamydia psittaci | – |
2 |
– |
1 |
3 |
– |
110 |
2 |
118 |
62 |
Mycoplasma pneumoniae | 5 |
170 |
9 |
376 |
281 |
28 |
239 |
38 |
1,146 |
1,234 |
Mycoplasma hominis | – |
9 |
– |
– |
– |
– |
– |
– |
9 |
2 |
Coxiella burnetii | 4 |
11 |
2 |
53 |
82 |
– |
16 |
10 |
178 |
251 |
Rickettsia spp | – |
– |
1 |
– |
– |
– |
3 |
6 |
10 |
2 |
Streptococcus group A | 22 |
12 |
6 |
315 |
– |
– |
135 |
– |
490 |
526 |
Streptococcus group B | 72 |
3 |
– |
– |
– |
– |
– |
– |
75 |
129 |
Yersinia enterocolitica | – |
11 |
– |
1 |
– |
– |
– |
– |
12 |
9 |
Brucella abortus | – |
1 |
– |
– |
2 |
– |
2 |
– |
5 |
2 |
Brucella species | – |
3 |
– |
4 |
– |
– |
– |
– |
7 |
5 |
Bordetella pertussis | 15 |
82 |
2 |
75 |
146 |
12 |
174 |
13 |
519 |
944 |
Legionella pneumophila | 1 |
3 |
– |
– |
8 |
– |
115 |
3 |
130 |
120 |
Legionella longbeachae | 1 |
2 |
1 |
– |
18 |
– |
22 |
40 |
84 |
78 |
Legionella species | – |
– |
– |
– |
– |
– |
18 |
– |
18 |
15 |
Cryptococcus species | – |
1 |
– |
9 |
16 |
– |
– |
– |
26 |
30 |
Leptospira species | – |
1 |
– |
15 |
8 |
– |
– |
2 |
26 |
18 |
Treponema pallidum | – |
125 |
95 |
478 |
448 |
– |
11 |
8 |
1,165 |
1,400 |
Entamoeba histolytica | – |
1 |
– |
2 |
– |
– |
4 |
7 |
14 |
28 |
Toxoplasma gondii | 1 |
14 |
– |
6 |
9 |
– |
8 |
3 |
41 |
28 |
Echinococcus granulosus | – |
– |
– |
– |
19 |
– |
2 |
– |
21 |
30 |
Total | 209 |
4,046 |
417 |
6,469 |
5,988 |
166 |
2,381 |
3,485 |
23,160 |
25,800 |
– No reports received.
Sixty-four per cent of the 14,755 reports received by LabVISE were viral infectious agents, and the remaining 36 per cent (8,405) were bacterial or other infectious agents. Among viruses, ortho/paramyxoviruses (influenza, parainfluenza and respiratory syncytial virus) were the most commonly reported (30%; 4,570) followed by herpesviruses (29%; 4,295) (Figure 65). Among non-viral infectious agents, Chlamydia trachomatis (4,296, 51%), Treponema pallidium (1,165, 14%) and Mycoplasma pneumoniae (1,146, 13%) were the most commonly reported pathogens.
Figure 65. Reports of viral infections to the Laboratory Virology and Serology Reporting Scheme, 2003, by viral group
This article {extract} was published in Communicable Diseases Intelligence Vol 29 No 1 March 2005 and may be downloaded as a full version PDF from the Table of contents page.
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 29 No 1, March 2005
NNDSS annual report, 2003
Communicable Diseases Intelligence